| Trial ID: | L1961 |
| Source ID: | NCT01033773
|
| Associated Drug: |
Antihyperglycemic Medication Guideline For Management Of Uncontrolled Hyperglycemia Presenting To The Ed Using Metformin, Sulfonylurea And/Or Insulin
|
| Title: |
Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)
|
| Acronym: |
STEP-DC
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01033773/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin|BEHAVIORAL: Diabetes survival skills self-management education
|
| Outcome Measures: |
Primary: Total Number of Hypoglycemia Events (Blood Glucose < 60mg/dL) Within 24 Hours of Baseline Visit, Total Number of hypoglycemic events defined as Blood Glucose \< 60 within 24 hours of index emergency room visit (baseline), 24 hours | Secondary: Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline, Mean difference in of blood glucose in mg/dl between baseline mean BG and end of intervention mean BG 30 days from baseline, 30 days|Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days, difference between mean hemoglobin A1C at baseline and mean Hemoglobin A1C to end of intervention, 30 days
|
| Sponsor/Collaborators: |
Sponsor: Medstar Health Research Institute
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
86
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-09
|
| Completion Date: |
2009-01
|
| Results First Posted: |
2020-10-05
|
| Last Update Posted: |
2020-10-05
|
| Locations: |
Washington Hospital Center, Washington, District of Columbia, 20010, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01033773
|
